Hemera Biosciences Overview
- Year Founded
-
2010
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
- Investors
-
1
Hemera Biosciences General Information
Description
Developer of a gene therapy platform designed for the treatment of age-related macular degeneration. The company's platform offers therapy with a patented complement-blocking drug targeting the progression of dry AMD (age-related macular degeneration) with a single interocular injection, thereby enabling patients to the treatment of both dry and wet macular degeneration.
Contact Information
Website
www.hemerabiosciences.comCorporate Office
- 800 South Street
- Suite 600
- Waltham, MA 02453
- United States
Corporate Office
- 800 South Street
- Suite 600
- Waltham, MA 02453
- United States
Hemera Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 25-Apr-2026 | Completed | Out of Business | |||
| 2. Early Stage VC (Series A) | 01-Apr-2013 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Aug-2010 | Completed | Startup |
Hemera Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Hemera Biosciences Comparisons
Industry
Financing
Details
Hemera Biosciences Competitors (53)
One of Hemera Biosciences’s 53 competitors is Clearside Biomedical, a Formerly VC-backed company based in Alpharetta, GA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Clearside Biomedical | Formerly VC-backed | Alpharetta, GA | ||||
| Complement Therapeutics | Venture Capital-Backed | London, United Kingdom | ||||
| AviadoBio | Venture Capital-Backed | London, United Kingdom | ||||
| Orchard Therapeutics | Formerly VC-backed | London, United Kingdom | ||||
| Allegro Ophthalmics | Venture Capital-Backed | San Juan Capistrano, CA |
Hemera Biosciences Signals
Hemera Biosciences Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Tufts University | University |
Hemera Biosciences FAQs
-
When was Hemera Biosciences founded?
Hemera Biosciences was founded in 2010.
-
Where is Hemera Biosciences headquartered?
Hemera Biosciences is headquartered in Waltham, MA.
-
What is the size of Hemera Biosciences?
Hemera Biosciences has 2 total employees.
-
What industry is Hemera Biosciences in?
Hemera Biosciences’s primary industry is Drug Discovery.
-
Is Hemera Biosciences a private or public company?
Hemera Biosciences is a Private company.
-
What is Hemera Biosciences’s current revenue?
The current revenue for Hemera Biosciences is .
-
How much funding has Hemera Biosciences raised over time?
Hemera Biosciences has raised $3.75M.
-
Who are Hemera Biosciences’s investors?
Tufts University has invested in Hemera Biosciences.
-
Who are Hemera Biosciences’s competitors?
Clearside Biomedical, Complement Therapeutics, AviadoBio, Orchard Therapeutics, and Allegro Ophthalmics are some of the 53 competitors of Hemera Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process